Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$1.04B |
| 2 |
Palo Alto Networks
PANW
|
+$957M |
| 3 |
Medtronic
MDT
|
+$433M |
| 4 |
Pinterest
PINS
|
+$422M |
| 5 |
Colgate-Palmolive
CL
|
+$396M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.38B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$967M |
| 3 |
Apple
AAPL
|
+$847M |
| 4 |
Meta Platforms (Facebook)
META
|
+$700M |
| 5 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$576M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.9% |
| 2 | Financials | 7.33% |
| 3 | Healthcare | 6.04% |
| 4 | Consumer Discretionary | 5.46% |
| 5 | Communication Services | 3.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
WPCB
3301
DELISTED
Warburg Pincus Capital Corporation I-B
WPCB
| $194K | ﹤0.01% |
19,781
| – | – |
|
3302
Direxion Daily Technology Bull 3x ETF
TECL
$6.16B
| $193K | ﹤0.01% |
6,905
+1,330
| +24% | +$52.9K |
|
3303
nCino
NCNO
$2.09B
| $192K | ﹤0.01% |
6,215
-620,134
| -99% | -$21.9M |
|
3304
Sprout Social
SPT
$609M
| $192K | ﹤0.01% |
3,298
-6,165
| -65% | -$358K |
|
3305
TFS Financial
TFSL
$4.98B
| $192K | ﹤0.01% |
13,972
-2,053
| -13% | -$30.2K |
|
3306
iRhythm Holdings
IRTC
$4.28B
| $191K | ﹤0.01% |
1,765
-83,235
| -98% | -$11M |
|
3307
Safe Bulkers
SB
$774M
| $191K | ﹤0.01% |
50,058
-6,610
| -12% | -$28.2K |
|
3308
Tootsie Roll Industries
TR
$3.02B
| $191K | ﹤0.01% |
6,096
-9,092
| -60% | -$275K |
|
3309
Clear Secure
YOU
$5.39B
| $191K | ﹤0.01% |
9,535
-19,838
| -68% | -$535K |
|
|
BFS
3310
Saul Centers
BFS
$809M
| $190K | ﹤0.01% |
4,027
-6,244
| -61% | -$308K |
|
3311
Boot Barn
BOOT
$4.93B
| $190K | ﹤0.01% |
2,756
-80,316
| -97% | -$6.88M |
|
3312
Credo Technology Group
CRDO
$45.5B
| $190K | ﹤0.01% |
16,234
-2,402
| -13% | -$27.9K |
|
3313
Global Partners
GLP
$1.68B
| $190K | ﹤0.01% |
8,047
+3,910
| +95% | +$104K |
|
3314
NI Holdings
NODK
$315M
| $190K | ﹤0.01% |
11,544
-969
| -8% | -$16K |
|
3315
Richmond Mutual Bancorp
RMBI
$256M
| $190K | ﹤0.01% |
13,567
-480
| -3% | -$7.36K |
|
3316
Theravance Biopharma
TBPH
$877M
| $190K | ﹤0.01% |
20,967
-7,657
| -27% | -$70.6K |
|
|
UDMY
3317
DELISTED
Udemy
UDMY
| $190K | ﹤0.01% |
18,621
+1,339
| +8% | +$16.2K |
|
3318
Global X S&P 500 Covered Call ETF
XYLD
$3.27B
| $190K | ﹤0.01% |
4,463
+4,213
| +1,685% | +$193K |
|
3319
Cytek Biosciences
CTKB
$541M
| $189K | ﹤0.01% |
17,651
-15,005
| -46% | -$149K |
|
3320
MacroGenics
MGNX
$252M
| $189K | ﹤0.01% |
63,950
+24,893
| +64% | +$131K |
|
|
FIRY
3321
Firy Inc
FIRY
$161M
| $189K | ﹤0.01% |
7,589
+3,784
| +99% | +$148K |
|
3322
Gildan
GIL
$10.9B
| $188K | ﹤0.01% |
6,546
+5,435
| +489% | +$174K |
|
3323
Kodiak Sciences
KOD
$2.86B
| $188K | ﹤0.01% |
24,511
+10,251
| +72% | +$72K |
|
3324
Sana Biotechnology
SANA
$974M
| $188K | ﹤0.01% |
29,197
-20,753
| -42% | -$132K |
|
|
TCN
3325
DELISTED
Tricon Residential Inc.
TCN
| $187K | ﹤0.01% |
18,474
-12,513
| -40% | -$161K |
|
Similar funds
Barclays's Q2 2022 Portfolio in Review
As of Q2 2022, Barclays held 5,544 positions worth $163B, up 28% from $128B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Barclays deployed $63.1B of net new capital in Q2 2022, opening 560 new positions and adding to 1,332 existing holdings. Its largest new stake was Fisker Inc.: 3,607,227 shares worth $30.9M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 22% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.38B trimmed.
- Barclays's largest Q2 2022 buy was Fisker Inc.: 3,607,227 shares worth $30.9M.
- Barclays added most to State Street Consumer Discretionary Select Sector SPDR ETF in Q2 2022, an estimated $1.04B increase.
- Barclays's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.38B.
- Barclays fully exited Cerner Corp in Q2 2022, selling an estimated $432M.
- Barclays's ten largest holdings make up 39% of its $163B portfolio in Q2 2022.
- Barclays opened 560 new positions and closed 413 in Q2 2022.
- Barclays's portfolio value rose 28% quarter-over-quarter to $163B.
Based on Barclays's 13F filing for Q2 2022, filed 12 Aug 2022.